Bsfllp Description


Print this page

Bill Ward, Ph.D.

Los Angeles

t: 310.752.2402
f: 310.752.2490
Download vCard

Areas of Practice


Intellectual Property


University of Chicago Law School, J.D., with honors; Order of the Coif, 2006; University Of Chicago Law Review Student Fellow, John M. Olin Program In Law And Economics

California Institute of Technology, Ph.D., Organic And Organometallic Chemistry , 2003

Language Spoken




Supreme Court Of The State Of California

United States Court Of Appeals: Federal Circuit

United States District Courts: Northern, Eastern, Central, and Southern Districts of California

Bill Ward’s main practice area is intellectual property litigation and counseling.

Dr. Ward has successfully represented companies in high-stakes patent and trade secret cases involving a wide range of technologies, including recombinant therapeutic antibodies, pharmaceuticals, medical devices, telecommunication systems, radio-frequency identification (RFID) systems, computer memory hardware, military hardware, and computer software.  Dr. Ward’s most recent representations have included a pharmaceutical company seeking to protect its brand name drug through Hatch-Waxman litigation and a global smartphone and computer company accused of infringing patents related to file identification, time-scale modification, and global positioning systems technologies.

Dr. Ward graduated from the University of Chicago Law School with high honors in 2006.  Before attending law school, Dr. Ward received a Ph.D. in organic and organometallic chemistry from the California Institute of Technology in Pasadena.  At Caltech, Dr. Ward was named a Special Institute Fellow and co-authored one of the most frequently requested journal articles in the chemical sciences.  Dr. Ward completed his thesis research on “Stereoselective Ruthenium-Catalyzed Olefin Metathesis” under the supervision of Prof. Robert H. Grubbs, co-recipient of the 2005 Nobel Prize in Chemistry.


Grubbs, R. H., Ward, D. W., Seiders, T. J., Goldberg, S. D., “Group 8 Transition Metal Carbene Complexes As Enantioselective Olefin Metathesis Catalysts,” U.S. Patent No. 7,683,180.

Seiders, T. J., Ward, D. W., Grubbs, R. H., “Enantioselective Ruthenium-Catalyzed Ring-Closing Metathesis,” Organic Letters 2001, 3, 3225-2338.

Related News

Boies, Schiller & Flexner Elects New Partners (December 16, 2014)